Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 5.86M
3: EX-10.34 Material Contract HTML 42K
4: EX-10.43 Material Contract HTML 70K
5: EX-10.44 Material Contract HTML 71K
2: EX-10.9 Material Contract HTML 42K
6: EX-14 Code of Ethics HTML 76K
7: EX-21.1 Subsidiaries List HTML 67K
8: EX-23.1 Consent of Expert or Counsel HTML 37K
12: EX-97 Clawback Policy re: Recovery of Erroneously HTML 59K
Awarded Compensation
9: EX-31.1 Certification -- §302 - SOA'02 HTML 42K
10: EX-31.2 Certification -- §302 - SOA'02 HTML 42K
11: EX-32 Certification -- §906 - SOA'02 HTML 40K
18: R1 Cover Page HTML 114K
19: R2 Audit Information HTML 43K
20: R3 Consolidated Balance Sheets HTML 156K
21: R4 Consolidated Balance Sheets (Parenthetical) HTML 56K
22: R5 Consolidated Statements of Income HTML 178K
23: R6 Consolidated Statements of Comprehensive Income HTML 145K
24: R7 Consolidated Statements of Changes in HTML 133K
Shareholders' Equity
25: R8 Consolidated Statements of Changes in HTML 43K
Shareholders' Equity (Parenthetical)
26: R9 Consolidated Statements of Cash Flows HTML 158K
27: R10 Summary of Significant Accounting Policies HTML 148K
28: R11 Investment Securities Available for Sale HTML 215K
29: R12 Loans and Allowance for Loan Losses HTML 962K
30: R13 Premises, Equipment and Software HTML 53K
31: R14 Goodwill and Other Intangible Assets HTML 100K
32: R15 Other Assets HTML 59K
33: R16 Deposits HTML 59K
34: R17 Other Short-term Borrowings and Long-term Debt HTML 91K
35: R18 Shareholders' Equity and Other Comprehensive HTML 134K
Income
36: R19 Regulatory Capital HTML 93K
37: R20 Net Income Per Common Share HTML 60K
38: R21 Fair Value Accounting HTML 335K
39: R22 Derivative Instruments HTML 189K
40: R23 Commitments and Contingencies HTML 72K
41: R24 Share-based Compensation and Other Employment HTML 119K
Benefit Plans
42: R25 Income Taxes HTML 142K
43: R26 Segment Reporting HTML 138K
44: R27 Condensed Financial Information of Synovus HTML 143K
Financial Corp. (Parent Company only)
45: R28 Subsequent Event HTML 40K
46: R29 Summary of Significant Accounting Policies HTML 201K
(Policies)
47: R30 Summary of Significant Accounting Policies HTML 53K
(Tables)
48: R31 Investment Securities Available for Sale (Tables) HTML 217K
49: R32 Loans and Allowance for Loan Losses (Tables) HTML 948K
50: R33 Premises, Equipment and Software (Tables) HTML 52K
51: R34 Goodwill and Other Intangible Assets (Tables) HTML 103K
52: R35 Other Assets (Tables) HTML 58K
53: R36 Deposits (Tables) HTML 58K
54: R37 Other Short-term Borrowings and Long-term Debt HTML 94K
(Tables)
55: R38 Shareholders' Equity and Other Comprehensive HTML 129K
Income (Tables)
56: R39 Regulatory Capital (Tables) HTML 89K
57: R40 Net Income Per Common Share (Tables) HTML 58K
58: R41 Fair Value Accounting (Tables) HTML 344K
59: R42 Derivative Instruments (Tables) HTML 179K
60: R43 Commitments and Contingencies (Tables) HTML 57K
61: R44 Share-based Compensation and Other Employment HTML 118K
Benefit Plans (Tables)
62: R45 Income Taxes (Tables) HTML 146K
63: R46 Segment Reporting (Tables) HTML 129K
64: R47 Condensed Financial Information of Synovus HTML 147K
Financial Corp. (Parent Company only) (Tables)
65: R48 Summary of Significant Accounting Policies HTML 129K
(Details)
66: R49 Investment Securities Available for Sale - Summary HTML 80K
Of Available For Sale Investment Securities
(Details)
67: R50 Investment Securities Available for Sale - HTML 59K
Narrative (Details)
68: R51 Investment Securities Available for Sale - HTML 87K
Schedule Of Unrealized Loss On Investments
(Details)
69: R52 Investment Securities Available for Sale - HTML 107K
Amortized Cost And Estimated Fair Value By
Contractual Maturity Of Investment Securities
Available For Sale (Details)
70: R53 Investment Securities Available for Sale - Summary HTML 44K
Of Sales Transactions In The Investment Securities
Available For Sale Portfolio (Details)
71: R54 Loans and Allowance for Loan Losses - Schedule Of HTML 152K
Current, Accruing Past Due And Nonaccrual Loans
(Details)
72: R55 Loans and Allowance for Loan Losses - Narrative HTML 96K
(Details)
73: R56 Loans and Allowance for Loan Losses - Loan HTML 369K
Portfolio Credit Exposure (Details)
74: R57 Loans and Allowance for Loan Losses - Schedule of HTML 60K
Allowances For Loan Losses and Recorded Investment
In Loans (Details)
75: R58 Loans and Allowance for Loan Losses - Amortized HTML 147K
Cost of Loans by Loan Portfolio Class (Details)
76: R59 Loans and Allowance for Loan Losses - Financial HTML 79K
Effect of Loan Modifications Made To Borrowers
Experiencing Financial Difficulty (Details)
77: R60 Loans and Allowance for Loan Losses - Aging HTML 127K
Analysis (Details)
78: R61 Loans And Allowance For Loan Losses - Troubled HTML 112K
Debt Restructurings (Details)
79: R62 Premises, Equipment and Software - Schedule of HTML 57K
Premises Equipment and Software (Details)
80: R63 Premises, Equipment and Software - Narrative HTML 44K
(Details)
81: R64 Goodwill and Other Intangible Assets - Narrative HTML 77K
(Details)
82: R65 Goodwill and Other Intangible Assets - Schedule of HTML 61K
Goodwill (Details)
83: R66 Goodwill and Other Intangible Assets - Other HTML 59K
Intangible Assets (Details)
84: R67 Goodwill and Other Intangible Assets - HTML 49K
Amortization Expense (Details)
85: R68 Other Assets - Schedule of Other Assets (Details) HTML 73K
86: R69 Other Assets - Narrative (Details) HTML 45K
87: R70 Deposits (Details) HTML 65K
88: R71 Other Short-term Borrowings and Long-term Debt - HTML 45K
Schedule of Short-term Borrowings (Details)
89: R72 Other Short-term Borrowings and Long-term Debt - HTML 49K
Additional Information on Synovus' Short-term
Borrowings (Details)
90: R73 Other Short-term Borrowings and Long-term Debt - HTML 96K
Schedule of Long-term Debt Instruments (Details)
91: R74 Other Short-term Borrowings and Long-term Debt - HTML 70K
Principal Payments on Long-term Debt (Details)
92: R75 Shareholders' Equity and Other Comprehensive HTML 82K
Income - Changes in Shares by Class (Details)
93: R76 Shareholders' Equity and Other Comprehensive HTML 76K
Income - Preferred Stock (Details)
94: R77 Shareholders' Equity and Other Comprehensive HTML 59K
Income - Common Stock (Details)
95: R78 Shareholders' Equity and Other Comprehensive HTML 73K
Income - OCI (Details)
96: R79 Regulatory Capital (Details) HTML 104K
97: R80 Net Income Per Common Share - Schedule of Basic HTML 69K
and Diluted Earnings Per Share (Details)
98: R81 Net Income Per Common Share - Narrative (Details) HTML 40K
99: R82 Fair Value Accounting - Financial Instruments HTML 165K
Measured At Fair Value On A Recurring Basis
(Details)
100: R83 Fair Value Accounting - Changes in Fair Value HTML 45K
Included in Consolidated Statements of Income
(Details)
101: R84 Fair Value Accounting - Changes In Level 3 Fair HTML 49K
Value Measurements (Details)
102: R85 Fair Value Accounting - Fair Value Measurements HTML 44K
and Valuation Techniques (Details)
103: R86 Fair Value Accounting - Assets And Liabilities HTML 59K
Measured At Fair Value On A Non-Recurring Basis
(Details)
104: R87 Fair Value Accounting - Valuation Techniques and HTML 63K
Significant Unobservable Inputs (Details)
105: R88 Fair Value Accounting - Carrying And Estimated HTML 142K
Fair Values Of Financial Instruments Carried On
Balance Sheet (Details)
106: R89 Derivative Instruments - Narrative (Details) HTML 70K
107: R90 Derivative Instruments - Impact Of Derivatives On HTML 78K
Balance Sheet (Details)
108: R91 Derivative Instruments - Effect Of Fair Value HTML 75K
Hedges On Consolidated Statements Of Income
(Details)
109: R92 Derivative Instruments - Schedule of the Carrying HTML 55K
Amount and Associated Cumulative Basis Adjustment
Related to the Application of Hedge Accounting
(Details)
110: R93 Derivative Instruments - Effect of Fair Value HTML 56K
Hedges on Consolidated Statements of Income
(Details)
111: R94 Commitments and Contingencies - Narrative HTML 70K
(Details)
112: R95 Commitments and Contingencies - Small Business HTML 72K
Loans (Details)
113: R96 Share-based Compensation and Other Employment HTML 79K
Benefit Plans - Narrative (Details)
114: R97 Share-based Compensation and Other Employment HTML 47K
Benefit Plans - Expenses (Details)
115: R98 Share-based Compensation and Other Employment HTML 61K
Benefit Plans - Stock Options (Details)
116: R99 Share-based Compensation and Other Employment HTML 54K
Benefit Plans - Fair Value Assumptions-RSUs
(Details)
117: R100 Share-based Compensation and Other Employment HTML 71K
Benefit Plans - Restricted Stock Units Activity
(Details)
118: R101 Share-based Compensation and Other Employment HTML 48K
Benefit Plans - Other Employee Benefit Plans
(Details)
119: R102 Income Taxes - Components of Income Tax Expense HTML 61K
(Details)
120: R103 Income Taxes - Effective Income Tax Reconciliation HTML 61K
(Details)
121: R104 Income Taxes - Deferred Tax Assets and Liabilities HTML 89K
(Details)
122: R105 Income Taxes - Narrative (Details) HTML 47K
123: R106 Income Taxes - Tax Carryforwards (Details) HTML 59K
124: R107 Income Taxes - Unrecognized Tax Benefits (Details) HTML 58K
125: R108 Segment Reporting - Narrative (Details) HTML 65K
126: R109 Segment Reporting - Schedule of Segment Reporting HTML 88K
Information, by Segment (Details)
127: R110 Condensed Financial Information of Synovus HTML 117K
Financial Corp. (Parent Company only) - Condensed
Balance Sheets (Details)
128: R111 Condensed Financial Information of Synovus HTML 90K
Financial Corp. (Parent Company only) - Condensed
Statements Of Income (Details)
129: R112 Condensed Financial Information of Synovus HTML 64K
Financial Corp. (Parent Company only) - Condensed
Statements of Comprehensive Income (Details)
130: R113 Condensed Financial Information of Synovus HTML 100K
Financial Corp. (Parent Company only) - Condensed
Statements of Cash Flows (Details)
131: R114 Subsequent Event (Details) HTML 54K
133: XML IDEA XML File -- Filing Summary XML 251K
136: XML XBRL Instance -- syn-20231231_htm XML 8.93M
132: EXCEL IDEA Workbook of Financial Report Info XLSX 369K
14: EX-101.CAL XBRL Calculations -- syn-20231231_cal XML 449K
15: EX-101.DEF XBRL Definitions -- syn-20231231_def XML 1.61M
16: EX-101.LAB XBRL Labels -- syn-20231231_lab XML 3.28M
17: EX-101.PRE XBRL Presentations -- syn-20231231_pre XML 2.24M
13: EX-101.SCH XBRL Schema -- syn-20231231 XSD 338K
134: JSON XBRL Instance as JSON Data -- MetaLinks 848± 1.34M
135: ZIP XBRL Zipped Folder -- 0000018349-24-000053-xbrl Zip 1.06M
1.I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2023 of Synovus Financial Corp.;
2.Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting,
or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting
that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.